Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHICKADEE: Brexanolone in Adolescent PPD
NCT03665038Phase 3Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Sep 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brexanolone in postpartum depression (PPD), sponsored by Supernus Pharmaceuticals, Inc.. Started Sep 2018; status: completed.
02
Drugs
brexanolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT03665038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03665038.